We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
Cap. Flow
+$5.74B
Cap. Flow %
6.15%
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$423M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$367M
3
XOM icon
ExxonMobil
XOM
+$337M
4
JNJ icon
Johnson & Johnson
JNJ
+$257M
5
BIIB icon
Biogen
BIIB
+$250M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$195M
2
ABBV icon
AbbVie
ABBV
+$188M
3
JPM icon
JPMorgan Chase
JPM
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$176M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$174M

Sector Composition

Rank Sector Weight
1 Healthcare 18.49%
2 Financials 16.75%
3 Technology 9.99%
4 Industrials 8.32%
5 Energy 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FONR
3451
DELISTED
Fonar
FONR
$24K ﹤0.01%
1,754
– –
TACT icon
3452
Transact Technologies
TACT
$51.7M
$24K ﹤0.01%
2,692
– –
PMD
3453
DELISTED
Psychemedics Corporation
PMD
$24K ﹤0.01%
2,424
+623
+35% +$7.26K
DXYN
3454
DELISTED
Dixie Group Inc
DXYN
$24K ﹤0.01%
2,900
– –
JASN
3455
DELISTED
Jason Industries, Inc.
JASN
$24K ﹤0.01%
5,366
+2,132
+66% +$11.5K
BKJ
3456
DELISTED
Bancorp of New Jersey, Inc.
BKJ
$24K ﹤0.01%
2,346
– –
MSL
3457
DELISTED
Midsouth Bancorp, Inc.
MSL
$24K ﹤0.01%
2,061
+453
+28% +$6.23K
ESIO
3458
DELISTED
Electro Scientific Industries
ESIO
$24K ﹤0.01%
5,070
– –
FSBK
3459
DELISTED
First South Bancorp Inc/VA
FSBK
$24K ﹤0.01%
3,052
– –
RCAP
3460
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
$24K ﹤0.01%
29,224
-1,248
-4% -$4.17K
AER icon
3461
AerCap
AER
$23.9B
$23K ﹤0.01%
600
-1,000
-63% -$44.2K
LNTH icon
3462
Lantheus
LNTH
$7.03B
$23K ﹤0.01%
+5,331
New +$35.9K
PFF icon
3463
PUT
iShares Preferred and Income Securities ETF
PFF
$13.2B
$23K ﹤0.01%
600
-249,400
-100% -$9.75M
IRD
3464
Opus Genetics
IRD
$277M
$23K ﹤0.01%
93
– –
ZYNE
3465
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$23K ﹤0.01%
+1,629
New +$40K
PRGX
3466
DELISTED
PRGX Global, Inc.
PRGX
$23K ﹤0.01%
6,115
-426
-7% -$1.66K
BTX.WS
3467
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$23K ﹤0.01%
27,619
+2,242
+9% +$2.03K
GI
3468
DELISTED
EndoChoice Holdings, Inc.
GI
$23K ﹤0.01%
+2,018
New +$31.6K
FAC
3469
DELISTED
First Acceptance Corp.
FAC
$23K ﹤0.01%
8,599
– –
ASPN icon
3470
Aspen Aerogels
ASPN
$385M
$22K ﹤0.01%
+2,875
New +$20.9K
CATX icon
3471
Perspective Therapeutics
CATX
$322M
$22K ﹤0.01%
1,594
– –
GAIA icon
3472
Gaia
GAIA
$48.1M
$22K ﹤0.01%
3,595
– –
PRSO icon
3473
Peraso
PRSO
$10.5M
$22K ﹤0.01%
2
– –
TSN icon
3474
PUT
Tyson Foods
TSN
$21.4B
$22K ﹤0.01%
+500
New +$21.3K
HMNF
3475
DELISTED
HMN Financial Inc
HMNF
$22K ﹤0.01%
1,907
– –
137 138
139
140 141

Similar funds

BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
BJ
BlackRock Japan Tokyo, Japan $30.3B AUM 13.85% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
CIM
Calvert Investment Management Bethesda, Maryland $2.67B AUM 16.23% 1-Year Est. Return
KAM
Keeley Asset Management Chicago, Illinois $2.35B AUM 26.92% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $1.69B AUM 8.84% 1-Year Est. Return

BlackRock Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.

  • BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
  • BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
  • BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
  • BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
  • BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
  • BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
  • BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.

Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.